Douglas Sborov, MD, MS

Assistant Professor
Huntsman Cancer Institute at the University of Utah
Salt Lake City, Utah, United States

BristolMyerSquibb (Consultant/Advisory Board)GlaxoSmithKline (Consultant/Advisory Board)Janssen (Consultant/Advisory Board)Legend Biotech (Consultant/Advisory Board)Sanofi (Consultant/Advisory Board)

Presentation(s):

• Comparison of Denosumab versus Bisphosphonates on Progression-free and Overall Survival in Newly Diagnosed Multiple Myeloma: A New User, Active Comparator Analysis of Real-World Data

  Sunday, August 28, 2022
  2:15 PM – 2:30 PM CEST